Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michele Merli

Showing results (41-50 of 117) with videos related to

Pageof 12
Sort By:
Blood Cells, Molecules & Diseases|March 3, 2009
Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoiresLuca Arcaini, Silvia Zibellini, Francesco Passamonti, et al.
European Journal of Haematology|July 29, 2010
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometryMichele Merli, Luca Arcaini, Emanuela Boveri, et al.
Human Pathology|August 4, 2009
High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphomaFrancesca Novara, Luca Arcaini, Michele Merli, et al.
Blood|November 11, 2011
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasmsLuca Arcaini, Silvia Zibellini, Emanuela Boveri, et al.
Blood|October 2, 2019
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter studyCarlo Visco, Francesco Rodeghiero, Alessandra Romano, et al.
Current Research in Translational Medicine|October 1, 2021
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal typeLorenzo Lazzari, Francesca Farina, Maria Teresa Lupo Stanghellini, et al.
Leukemia & Lymphoma|April 29, 2020
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphomaMichele Merli, Irene Defrancesco, Carlo Visco, et al.
Frontiers in Oncology|December 23, 2021
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana LinfomiLaura Ballotta, Pier Luigi Zinzani, Stefano Pileri, et al.
Haematologica|December 22, 2022
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphomaMaria Cristina Pirosa, Marianna Sassone, Barbara Kiesewetter, et al.
British Journal of Haematology|April 25, 2022
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamicsEleonora Calabretta, Anna Guidetti, Francesca Ricci, et al.
Pageof 12

Showing results (41-50 of 117) with videos related to

Sort By:
Pageof 12
Blood Cells, Molecules & Diseases|March 3, 2009
Splenic marginal zone lymphoma: Clinical clustering of immunoglobulin heavy chain repertoiresLuca Arcaini, Silvia Zibellini, Francesco Passamonti, et al.
European Journal of Haematology|July 29, 2010
Assessment of bone marrow involvement in non-Hodgkin's lymphomas: comparison between histology and flow cytometryMichele Merli, Luca Arcaini, Emanuela Boveri, et al.
Human Pathology|August 4, 2009
High-resolution genome-wide array comparative genomic hybridization in splenic marginal zone B-cell lymphomaFrancesca Novara, Luca Arcaini, Michele Merli, et al.
Blood|November 11, 2011
The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasmsLuca Arcaini, Silvia Zibellini, Emanuela Boveri, et al.
Blood|October 2, 2019
Eltrombopag for immune thrombocytopenia secondary to chronic lymphoproliferative disorders: a phase 2 multicenter studyCarlo Visco, Francesco Rodeghiero, Alessandra Romano, et al.
Current Research in Translational Medicine|October 1, 2021
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal typeLorenzo Lazzari, Francesca Farina, Maria Teresa Lupo Stanghellini, et al.
Leukemia & Lymphoma|April 29, 2020
Direct-acting antivirals in relapsed or refractory hepatitis C virus-associated diffuse large B-cell lymphomaMichele Merli, Irene Defrancesco, Carlo Visco, et al.
Frontiers in Oncology|December 23, 2021
Venetoclax Shows Low Therapeutic Activity in BCL2-Positive Relapsed/Refractory Peripheral T-Cell Lymphoma: A Phase 2 Study of the Fondazione Italiana LinfomiLaura Ballotta, Pier Luigi Zinzani, Stefano Pileri, et al.
Haematologica|December 22, 2022
IELSG40/CLEO phase II trial of clarithromycin and lenalidomide in relapsed/refractory extranodal marginal zone lymphomaMaria Cristina Pirosa, Marianna Sassone, Barbara Kiesewetter, et al.
British Journal of Haematology|April 25, 2022
Chemotherapy after PD-1 inhibitors in relapsed/refractory Hodgkin lymphoma: Outcomes and clonal evolution dynamicsEleonora Calabretta, Anna Guidetti, Francesca Ricci, et al.
Pageof 12